pharma news today glp-1 Are weight-loss drugs quietly reshaping how people eat? Could reduced appetite and smaller portion sizes change the future of food innovation? And what does this shift mean for the growing role This is the worst the

Odds of gastrointestinal events were similar between tirzepatide and GLP-1 RAs, except for diarrhoea with tirzepatide 10 mg (OR 1.51 [95% CI 1.07, 2.15], I 2 0%) (Table 2)

Sleep apnea, and particularly obstructive sleep apnea, is highly prevalent in patients with cardiovascular disease (CVD), including heart failure, stroke, atrial fibrillation, and end-stage renal disease

Finally, source quality is everything: Contaminated peptides from gray-market suppliers are the real danger peptide users should be worried about (especially if the user improperly reconstitutes and doses them due to human error)

Destructive herpetic whitlow in AIDS: report of three cases